Pharmacogenetic Dosing of Epirubicin in FEC Chemotherapy
Epirubicin is a common chemotherapy medication used in the treatment of breast cancer.
However, chemotherapy dosing is calculated based on people's height and weight, which may
not be the most accurate way. The purpose of this study is to see if epirubicin dosing based
on people's genetic profiles is better than the usual methods.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society